| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/28/2002 | WO2002016410A2 Peptide selection method |
| 02/28/2002 | WO2002016409A2 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
| 02/28/2002 | WO2002016408A2 Gpe analogs |
| 02/28/2002 | WO2002016407A2 Sh2 domain binding inhibitors |
| 02/28/2002 | WO2002016405A1 S-nitrosothiols and their use as medicaments for cardiovascular diseases |
| 02/28/2002 | WO2002016404A1 Cyclic peptide derivative |
| 02/28/2002 | WO2002016390A1 21 human secreted proteins |
| 02/28/2002 | WO2002016389A1 23 human secreted proteins |
| 02/28/2002 | WO2002016381A2 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | WO2002016309A1 Compounds and compositions for delivering active agents |
| 02/28/2002 | WO2002015977A2 Methods and compositions for treating ige-related disease using nnt-1 inhibitors |
| 02/28/2002 | WO2002015959A2 Compounds and compositions for delivering active agents |
| 02/28/2002 | WO2002015941A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 02/28/2002 | WO2002015937A2 Pharmaceutical composition for the systematic administration of pharmacologically active ingredients containing polyol fatty acid esters |
| 02/28/2002 | WO2002015928A1 METHOD OF ADMINISTERING FimH PROTEIN AS A VACCINE FOR URINARY TRACT INFECTIONS |
| 02/28/2002 | WO2002015927A1 High mannose proteins and methods of making high mannose proteins |
| 02/28/2002 | WO2002015926A1 c-mpl LIGAND-CONTAINING MEDICINAL COMPOSITIONS FOR INCREASING PLATELETS AND ERYTHROCYTES |
| 02/28/2002 | WO2002015925A1 Methof of regulating apoptosis and apoptosis-regulatory polypeptide |
| 02/28/2002 | WO2002015924A1 Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer |
| 02/28/2002 | WO2002015923A1 Orally administered peptides to ameliorate atherosclerosis |
| 02/28/2002 | WO2002015922A2 New uses for amino acid anticonvulsants for treatment of pain |
| 02/28/2002 | WO2002015921A2 Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | WO2002015919A2 Saratin for inhibiting platelet adhesion to collagen |
| 02/28/2002 | WO2002015918A2 Method and compositions for promoting osteogenesis |
| 02/28/2002 | WO2002015895A2 Alpha-difluoromethylornithine (dfmo) use in the human prostate |
| 02/28/2002 | WO2002015893A2 Treatment of wounds |
| 02/28/2002 | WO2002015882A1 Delayed release compositions and combinations |
| 02/28/2002 | WO2002015881A2 Use of a porous carrier |
| 02/28/2002 | WO2002015879A1 A method of treating a systemic disease |
| 02/28/2002 | WO2002015846A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/28/2002 | WO2002015700A1 Prodrugs activated by plasmin and their use in cancer chemotherapy |
| 02/28/2002 | WO2002015664A2 Methods of preventing or treating west nile virus and other infections |
| 02/28/2002 | WO2002015661A2 Inhibitors of hiv replication and method of treatment of hiv infections |
| 02/28/2002 | WO2002009667A9 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/28/2002 | WO2001095924A3 Method for treating a movement disorder |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085196A3 Cxcr4 antagonist treatment of hematopoietic cells |
| 02/28/2002 | WO2001083747A3 Prion proteins and their uses |
| 02/28/2002 | WO2001082961A3 Methods for treating bone tumors |
| 02/28/2002 | WO2001081595A3 Human caspase-14 compositions |
| 02/28/2002 | WO2001081361A8 Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death |
| 02/28/2002 | WO2001079446A3 Materials and methods relating to lipid metabolism |
| 02/28/2002 | WO2001079437A3 Novel polypeptide a human cell differential transcriptional factor 14 and polynucleotide encoding it |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079216A3 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 02/28/2002 | WO2001079167A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/28/2002 | WO2001078796A9 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 02/28/2002 | WO2001078767A3 Pharmaceutical preparations comprising modified peptides |
| 02/28/2002 | WO2001076636A3 Pharmaceutical composition of modified pna molecules |
| 02/28/2002 | WO2001076615A3 Cxcr4 agonist treatment of hematopoietic cells |
| 02/28/2002 | WO2001075064A3 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 02/28/2002 | WO2001074378A3 Promoting cell growth by inhibiting enabled proteins or their ligands |
| 02/28/2002 | WO2001070997A3 Regulation of human leucine aminopeptidase-like enzyme |
| 02/28/2002 | WO2001070255A3 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 02/28/2002 | WO2001068852A3 Apolipoprotein-a-i regulation of t-cell signalling |
| 02/28/2002 | WO2001064839A3 Novel macrophage nucleic acids and polypeptides |
| 02/28/2002 | WO2001060998A3 Small oligonucleotides with anti-tumor activity |
| 02/28/2002 | WO2001058936A3 Constructs for delivery of therapeutic agents to neuronal cells |
| 02/28/2002 | WO2001057273A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver |
| 02/28/2002 | WO2001057188A3 Novel nucleic acids and polypeptides |
| 02/28/2002 | WO2001055327A3 Nucleic acids, proteins, and antibodies |
| 02/28/2002 | WO2001055213A3 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds |
| 02/28/2002 | WO2001049309A3 Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue |
| 02/28/2002 | WO2001046260A3 Novel immunoglobulin superfamily members apex-1, apex-2 and apex-3 and uses thereof |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001042462A3 Phospholipase a2 inhibitory peptides from python reticulatus |
| 02/28/2002 | WO2001038547A3 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 02/28/2002 | WO2001036656B1 A complex between hyaluronic acid and a biomolecule and its use |
| 02/28/2002 | WO2001032851A3 Modular transport systems for molecular substances and production and use thereof |
| 02/28/2002 | WO2001027261A3 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 02/28/2002 | WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 02/28/2002 | WO2001005422A3 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 02/28/2002 | WO2000078328A3 USE OF GROWTH HORMONE (hGH) FOR THE TREATMENT OF SEXUAL FUNCTIONAL DISTURBANCES |
| 02/28/2002 | WO2000077037A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/28/2002 | US20020026655 Genetically engineered Salmonella for use in the treatment of cancer |
| 02/28/2002 | US20020026143 Sensor system including port body |
| 02/28/2002 | US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 02/28/2002 | US20020026042 Utilizing rabbit G alpha 16 polypeptides and polynucleotides in screening of antagonists or agonists of cells co-expressing a G-protein coupled receptor and rabbit G alpha 16; targets for drug discovery |
| 02/28/2002 | US20020026041 Flea allantoinase nucleic acid molecules, proteins and uses thereof |
| 02/28/2002 | US20020026040 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases |
| 02/28/2002 | US20020026037 For diagnosing and treating disorders related to this novel human protein such as disorders related to the vascular and lymphatic systems |
| 02/28/2002 | US20020026036 Constructing cassette vector by inserting cDNA coding for heavy chain constant region of human antibody into expression vector for animal cell use, establishing cloning site, digesting cdna coding for heavy chain, inserting into vector |
| 02/28/2002 | US20020026033 Synthetic glycosulfopeptides and methods of synthesis thereof |
| 02/28/2002 | US20020025949 Anti-epileptogenic agents |
| 02/28/2002 | US20020025941 Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal |
| 02/28/2002 | US20020025939 Chorionic gonadortropin dna vaccines and methods |
| 02/28/2002 | US20020025935 Antiinflammatory agents; autoimmune diseases; central nervous system disorders |
| 02/28/2002 | US20020025933 GLP-2 derivatives |
| 02/28/2002 | US20020025932 Binding; elution |
| 02/28/2002 | US20020025930 Ras-like protein |
| 02/28/2002 | US20020025929 Concurrent aministering parathyroid hormone and benzothiophene compound |
| 02/28/2002 | US20020025928 Pentapeptides |
| 02/28/2002 | US20020025927 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 02/28/2002 | US20020025925 Combination therapy |
| 02/28/2002 | US20020025924 Novel lipopeptides as antibacterial agents |
| 02/28/2002 | US20020025923 Antiinflammatory agents |
| 02/28/2002 | US20020025921 Composition and method for growing, protecting, and healing tissues and cells |